We are glad to announce the launch of GELSECTAN® in Finland by our partner company Sabora.
GELSECTAN® belongs to a new class of products defined as “mucosal protectors”, which help restore the normal function of the epithelial barrier in the gut. It is intended to relieve and prevent IBS symptoms such as chronic or relapsing diarrhea, pain and bloating.
GELSECTAN® is already marketed in Spain, Portugal, Greece, Germany, Netherlands and Belgium. Other European countries, including Austria, Hungary, Italy, Romania and France will follow within the next few months.
GELSECTAN® is a class IIa medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments (CE 0476, Noventure SL). It is available in the Belgian market since September 2018.
In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.